52 Week Range
As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Miraca Holdings To Buy All Shares Of Tokyo-Based Selmesta
R&I affirms Miraca Holdings's rating at "A" and says stable outlook
Fujirebio Says Entered Into Agreement With Janssen Pharmaceuticals
H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
Shinjuku Mitsui Bldg.
Representative Executive Officer, President, Group Chief Executive Officer, Director
Chief Financial Officer, Executive Officer, Chairman & Chief Executive Officer of Subsidiaries, Director
Chief Operating Officer, Chief Information Officer, Vice President, Representative Executive Officer, Director
Executive Officer, Chief Director of Planning Administration
Executive Officer, President of Subsidiary
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Japanese industrial conglomerates Hitachi Ltd and Toshiba Corp will join with Miraca Holdings to increase production of antigen-based coronavirus tests, aiding in the country's effort to screen more people for the new virus.
Japanese industrial conglomerates Hitachi Ltd and Toshiba Corp, and Miraca Holdings subsidiary Fujirebio will jointly set up a plant in northern Japan to produce antigen coronavirus testing kits, the three companies said on Friday.
Japan's Miraca Holdings subsidiary Fujirebio on Monday applied for government approval for the nation's first antigen coronavirus testing kits, a health ministry official said.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.